Cambridge Investment Research Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-140,331
Closed -$13.9M 2520
2019
Q3
$13.9M Buy
140,331
+107,440
+327% +$10.2M 0.12% 173
2019
Q2
$3.04M Sell
32,891
-9,997
-23% -$949K 0.03% 563
2019
Q1
$4.05M Sell
42,888
-13,451
-24% -$1.18M 0.04% 441
2018
Q4
$3.61M Buy
56,339
+12,975
+30% +$958K 0.04% 431
2018
Q3
$3.88M Buy
43,364
+2,020
+5% +$179K 0.04% 445
2018
Q2
$3.28M Sell
41,344
-4,329
-9% -$359K 0.03% 472
2018
Q1
$4.08M Buy
45,673
+8,323
+22% +$799K 0.05% 375
2017
Q4
$3.9M Buy
37,350
+2,459
+7% +$277K 0.05% 373
2017
Q3
$5.09M Buy
34,891
+452
+1% +$61.6K 0.07% 281
2017
Q2
$4.47M Buy
34,439
+3,654
+12% +$448K 0.07% 281
2017
Q1
$3.83M Sell
30,785
-5,582
-15% -$668K 0.07% 285
2016
Q4
$4.21M Buy
36,367
+98
+0.3% +$10.9K 0.08% 240
2016
Q3
$3.79M Buy
36,269
+1,352
+4% +$146K 0.07% 270
2016
Q2
$3.44M Sell
34,917
-1,923
-5% -$199K 0.07% 263
2016
Q1
$3.69M Sell
36,840
-6,232
-14% -$642K 0.08% 221
2015
Q4
$5.16M Buy
43,072
+1
+0% +$116 0.12% 155
2015
Q3
$4.66M Sell
43,071
-2,802
-6% -$348K 0.13% 146
2015
Q2
$5.31M Buy
45,873
+1,420
+3% +$162K 0.15% 145
2015
Q1
$5.13M Sell
44,453
-1,019
-2% -$122K 0.15% 145
2014
Q4
$5.09M Buy
45,472
+2,581
+6% +$272K 0.16% 128
2014
Q3
$4.07M Buy
42,891
+11,571
+37% +$1.04M 0.12% 166
2014
Q2
$2.69M Buy
31,320
+1,578
+5% +$120K 0.09% 214
2014
Q1
$2.08M Buy
29,742
+6,274
+27% +$497K 0.08% 248
2013
Q4
$1.98M Buy
23,468
+1,080
+5% +$85.5K 0.08% 236
2013
Q3
$1.73M Buy
22,388
+2,124
+10% +$149K 0.08% 248
2013
Q2
$1.19M Buy
+20,264
New +$1.22M 0.06% 284

Other funds holding CELG

Cambridge Investment Research Advisors's CELG Position: Q4 2019 in Review

Cambridge Investment Research Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 140,331 shares — an estimated $13.9M sold.

Cambridge Investment Research Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $13.9M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Cambridge Investment Research Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 140,331 Celgene Corp shares in Q4 2019, an estimated $13.9M.
  • Cambridge Investment Research Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Cambridge Investment Research Advisors's Celgene Corp position peaked at $13.9M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2019, filed 4 Feb 2020.